Old and new insights in the treatment of thyroid carcinoma
- PMID: 21048836
- PMCID: PMC2956973
- DOI: 10.4061/2010/279468
Old and new insights in the treatment of thyroid carcinoma
Abstract
Thyroid cancer is the endocrine tumor that bears the highest incidence with 33 550 new cases per year. It bears an excellent prognosis with a mortality of 1530 patients per year (Jemal et al.; 2007). We have been treating patients with thyroid carcinoma during many years without many innovations. Recently, we have assisted to the development of new agents for the treatment of this disease with unexpected good results. Here we present a review with the old and new methods for the treatment of this disease.
Figures
References
-
- Hay ID. Papillary thyroid carcinoma. Endocrinology and Metabolism Clinics of North America. 1990;19(3):545–576. - PubMed
-
- Lin J-D, Chao T-C, Huang B-Y, Chen S-T, Chang H-Y, Hsueh C. Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology. Thyroid. 2005;15(7):708–717. - PubMed
-
- Rojeski MT, Gharib H. Nodular thyroid disease. Evaluation and management. New England Journal of Medicine. 1985;313(7):428–436. - PubMed
-
- Mazzaferri EL. Management of a solitary thyroid nodule. New England Journal of Medicine. 1993;328(8):553–559. - PubMed
-
- Tollin SR, Mery GM, Jelveh N, et al. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid. 2000;10(3):235–241. - PubMed
LinkOut - more resources
Full Text Sources